TB CAB

Advocates encourage the health authorities in Peru to approve the endTB study

TB advocates stress the importance of the observational endTB study for expanding access to new treatments for multidrug-resistant TB in Peru.

Read More →

Advocates maintain pressure on the Ministry of Health to facilitate access to delamanid in Peru

TB advocates reiterate the important role the Ministry of Health must play in facilitating access to delamanid for Peruvians with multidrug-resistant TB.

Read More →

Advocates encourage Danaher to continue investments in Cepheid’s TB products

TB advocates encourage Danaher, a holdings company that recently acquired Cepheid, to prioritize the continued development of critical Cepheid products for TB.

Read More →

Advocates call for the Ministry of Health in Peru to facilitate access to delamanid

TB advocates encourage the Ministry of Health in Peru to develop country guidance on the use of delamanid for the treatment of drug-resistant TB, a first step to facilitating access.

Read More →

Urgent action required to end bureaucratic delays and expedite enrollment of the NExT study

TB advocates addressed the University of Limpopo and Sefako Makgatho Health Science University demanding the immediate release of funds for the NeXT study.

Read More →

Activists call for withdrawal of substandard TB test from India

TB activists urge the Drug Controller General of India to withdraw GeneDrive test for TB from the Indian market.

Read More →

Advocates call for the Ministry of Health in Cote d’Ivoire to adopt new TB test

TB advocates urge the Ministry of Health in Cote d’Ivoire to introduce a new, simple, and rapid TB test, TB LAM, which detects TB antigens in urine, and is an important tool for detecting TB in certain populations living with HIV.

Read More →

Advocates, alarmed by appalling global response to MDR-TB outbreak in Papua New Guinea, call on international agencies to take action

Advocates denounced the global response to an MDR-TB outbreak in Papua New Guinea and urged international agencies to immediately intervene.

Read More →

Urgent need to scale up access to new treatment options for MDR-TB in the Philippines

Given the urgent need to address the MDR-TB epidemic in the Philippines, advocates urge for rapid delivery of the new treatment options to people with MDR-TB.

Read More →

Appeal to develop VXc-486 for tuberculosis

Advocates urge Vertex to assure the timely and responsible development of drug candidate VXc-486 for tuberculosis.

Read More →

Page 1 of 4 · Total posts: 10

1 2 Last→